Genmab A/S
GMAB · OMX
$43.79+$3.79 (+9.47%)TodayMarket closed ·
Prev close $40.00
Who owns GMAB
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 23.0% of GMAB’s shares.
- BlackRock Institutional Trust Company, N.A.5.9%
- Orbis Investment Management Ltd.3.5%
- Vanguard Capital Management, LLC2.9%
- Wellington Management Company, LLP2.3%
- Next 6 largest institutions8.4%
- All other shareholders77.0%
| Holder | Shares | % of shares |
|---|---|---|
| BlackRock Institutional Trust Company, N.A. | 3.71M | 5.94% |
| Orbis Investment Management Ltd. | 2.19M | 3.51% |
| Vanguard Capital Management, LLC | 1.82M | 2.92% |
| Wellington Management Company, LLP | 1.42M | 2.28% |
| Amundi Asset Management, SAS | 1.40M | 2.24% |
| Aviva Investors Global Services Limited | 1.16M | 1.86% |
| Norges Bank Investment Management (NBIM) | 776.35K | 1.24% |
| Schroder Investment Management North America Inc. | 686.10K | 1.10% |
| de Winkel (Jan van) | 658.93K | 1.06% |
| BlackRock Advisors (UK) Limited | 542.49K | 0.87% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Health Care Fund | 1.35M | 2.16% |
| Vanguard Total International Stock Index Fund | 883.56K | 1.42% |
| Statens Pensjonsfond Utland | 776.35K | 1.24% |
| Vanguard International Growth Fund | 635.35K | 1.02% |
| Vanguard Developed Markets Index Fund | 584.86K | 0.94% |
Congressional trades
Disclosed by members of Congress over the last 12 months
| Member | Type | Amount | Traded |
|---|---|---|---|
| Alan ArmstrongSenator | Purchase | $1K–$15K | Mar 30, 2026 |
Short interest
Settled Sep 30, 2026
- Shares short
- 6.06M
- Days to cover
- 2.09
- % of shares outstanding
- 9.71%
- Average daily volume
- 2.89M
- Change since last report
- +23.2%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.